News About: Pharm. Industry
Pharmaceutical saleswomen in unutterable distress
The number of young female workers is growing at a faster pace than their male counterparts these days as women increasingly outpace men in the job market.
More young women are getting a higher education, delaying...
Multinational firms start layoff programs
Sanofi Aventis Korea and GlaxoSmithKline are restructuring theirs workforce through a voluntary retirement program in an effort to cope with sluggish sales here due to the government-mandated cuts in drug prices in Ap...
Pharmaceutical firms behind London Olympics
Korea cemented its status as a sporting powerhouse, surpassing its initial goal of 10 golds and achieving a top 10 finish at the London Olympics.
Heading into the last day of the 30th Summer Games, the nation is si...
MSD names new execs in shake-up
MSD Korea, the subsidiary of the U.S. pharmaceutical firm Merck & Co., Friday promoted Paik Chong-min, Quality Control manager as the head of Asia-Pacific quality control business units in a management reshuffle.
T...
CTCBIO to inject 64.5 billion won into vaccine projects
CTC Bio, a local biopharmaceutical company, said Friday it will inject 64.5 billion won, 14.38 percent of its stake, by December 30, 2013 into projects at expanding its manufacturing facilities for vaccines, injectabl...
Korean scientist focuses on cloning human stem cells
Professor Park Se-pill at Jeju National University is striving to clone human embryonic stem cells, the much-touted breakthrough that no scientists have ever achieved.
The embryologist has started cloning human emb...
Pharmacy seeing revival
Recently, more and more television dramas are adding the ninth decade to their retro-reservoir, allowing celebrities who enjoyed their heyday two decades ago to return to the spotlight.
The release of “Architecture...
Yuhan teams up with Theragen Etex
Yuhan Corporation said Thursday it has signed a DNA sequencing service deal with Theragen Etex, a biopharmaceutical firm, in a move to help expand its presence in the domestic human genome service market.
Under the...
Nagoya protocol will hurt pharmaceutical sector
A report released on Wednesday said Korea's pharmaceutical sector could lose up to 200 billion won if a new treaty on the use of genetic resources goes through.
The estimated losses are based on an assumption that...
Government to back two companies’ drug development
Daewoong Pharmaceutical plans to develop a combination drug for treatment of cardiovascular disease, and HanAll Biopharma will also carry out clinical trials for its sustained-release pulmonary hypertension drug with ...
